News Detail
New Delhi, 20 Jan 2025: Immuneel Therapeutics, the Bengaluru-based cell and gene therapy company, has launched India's second CAR-T cell therapy Qartemi to treat patients with B-cell Non-Hodgkin Lymphoma (B-NHL) - an aggressive form of blood cancer - at less than one-tenth of the......
View Details
Source : Economic Times
CAR-T cell therapy
blood cancer treatment
Immuneel Therapeutics
B-cell Non-Hodgkin Lymphoma
low-cost cancer therapy
Kiran Mazumdar-Shaw
Chimeric antigen receptor therapy
clinical trial results
oncology
India cancer treatment
Related News
- EMA has recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 (20-01-2025)
- IPC to host 'World Pharmacopoeia meet' next month (20-01-2025)
- Video clip of IIT Madras Director Kamakoti favouring 'Gomutra' goes viral (20-01-2025)
- Puducherry scientist develops high-yielding pepper variety (19-01-2025)
- Pharma firm raided in Baddi by ANTF again (19-01-2025)
- 2.70 lakh Narcotic Pills recovered in Sirsa, driver detained, handed over to DCO (19-01-2025)
- Arrest warrant for Baba Ramdev and Balakrishna (19-01-2025)
- Piramal Pharma Converts Coal-Fired Steamer at Digwal Facility to Operate on Biomass Briquettes (19-01-2025)
- Bharat Biotech launches Rs 1,500 cr mega vaccine production hub in Odisha (19-01-2025)
- Glenmark Pharma retrenches over 100 personnel from its consumer care division (19-01-2025)